Clinical trials
Phase 2 Sarcoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Terminated | 7 |
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 13 |
| Children's Oncology Group | 6 |
| University Health Network, Toronto | 6 |
| Gynecologic Oncology Group | 4 |
| NCIC Clinical Trials Group | 3 |
| Radiation Therapy Oncology Group | 3 |
| AHS Cancer Control Alberta | 2 |
| Bayer | 2 |
| Daiichi Sankyo | 2 |
| Eli Lilly and Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 58 |
| Neuroectodermal Tumors, Primitive, Peripheral | 10 |
| Rhabdomyosarcoma | 10 |
| Neuroblastoma | 9 |
| Osteosarcoma | 8 |
| Central Nervous System Neoplasms | 7 |
| Medulloblastoma | 6 |
| Breast Neoplasms | 5 |
| Head and Neck Neoplasms | 5 |
| Astrocytoma | 4 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.